Literature DB >> 16377451

Outpatient substance abuse treatment and HIV prevention: an update.

Harold A Pollack1, Thomas D'Aunno, Barbara Lamar.   

Abstract

Testing and counseling, along with community outreach, have been identified as valuable in the prevention of human immunodeficiency virus (HIV) and other blood-borne diseases. This article assesses the extent to which outpatient substance abuse treatment (OSAT) programs provide such services. Longitudinal data for 1988-2000 were analyzed from the National Drug Abuse Treatment System Survey (NDATSS). Random-effects regression was used to examine factors associated with the provision of prevention services. HIV testing, which had became more common between 1990 and 1995, continued to proliferate between 1995 and 2000. The proportion of units that provide HIV testing and counseling increased from 66% to 86%. The proportion of units that provide HIV community outreach increased significantly before 1995 but then slightly decreased from 77% to 73% between 1995 and 2000. In conclusion, HIV testing and counseling widely proliferated in OSAT care. However, OSAT units remain less likely to offer HIV community outreach services.

Entities:  

Mesh:

Year:  2006        PMID: 16377451     DOI: 10.1016/j.jsat.2005.09.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  29 in total

1.  Managerial capacity and adoption of culturally competent practices in outpatient substance abuse treatment organizations.

Authors:  Erick G Guerrero
Journal:  J Subst Abuse Treat       Date:  2010-08-21

2.  Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States.

Authors:  Edmund J Bini; Steven Kritz; Lawrence S Brown; Jim Robinson; Don Alderson; John Rotrosen
Journal:  J Addict Dis       Date:  2011-04

3.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

4.  Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S.

Authors:  Erick G Guerrero; Julie A Cederbaum
Journal:  Int J Drug Policy       Date:  2010-10-20

5.  Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.

Authors:  Lydia Aletraris; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2015-04-13

Review 6.  Drug treatment as HIV prevention: a research update.

Authors:  David S Metzger; George E Woody; Charles P O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

7.  Sustainment of smoking cessation programs in substance use disorder treatment organizations.

Authors:  Hannah K Knudsen; Jessica Muilenburg; Lillian T Eby
Journal:  Nicotine Tob Res       Date:  2012-11-06       Impact factor: 4.244

8.  Organizational characteristics that foster early adoption of cultural and linguistic competence in outpatient substance abuse treatment in the United States.

Authors:  Erick G Guerrero
Journal:  Eval Program Plann       Date:  2012-02

9.  Organizational capacity for service integration in community-based addiction health services.

Authors:  Erick G Guerrero; Gregory A Aarons; Lawrence A Palinkas
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

10.  Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programs.

Authors:  Peter D Friedmann; Lan Jiang; Jeffrey A Alexander
Journal:  J Behav Health Serv Res       Date:  2009-03-19       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.